THEM6 and neoplasm: The immune-inhibited oncogenic pathways were associated with the noninflammatory TME, that was, a blockage of the formation of immune-inhibited carcinogenic pathways can improve the noninflammatory TME resulted by THEM6, so as to reactivate the immune system of the tumor and play a therapeutic role.